Distribution and Metabolism of (5-hydroxymethyl)furfural in Male F344 Rats and B6C3F1 Mice After Oral Administration
Overview
Toxicology
Affiliations
(5-Hydroxymethyl)furfural (HMF), a heat-induced decomposition product of hexoses, is present in food and drink. Recent reports have shown HMF to be an in vitro mutagen after sulfate conjugation and to be a promoter as well as a weak initiator of colonic aberrant foci in rats. In order to investigate the metabolic activation further and to provide information for HMF toxicology studies, the disposition of [14C]-HMF has been investigated in male F344 rats and B6C3F1 mice following po administration of either 5, 10, 100, or 500 mg/kg. Tissue distribution results indicated that absorption of HMF was rapid in male rats and mice and that tissue concentrations in male mice at the earliest time point are not linearly proportional to dose. Excretion was primarily via the urine in both, with 60-80% of the administered dose excreted by this route in 48 h. Tissue/blood ratios of HMF-derived radioactivity were greater than 1 for liver and kidney. Three metabolites were identified and quantitated in urine. Formation of one of the metabolites, N-(5-hydroxymethyl-2-furoyl)glycine, was inversely proportional to dose in rats but not mice. None of the metabolites were sulfate conjugates nor likely to be formed from sulfate conjugates. There were relatively low levels of nonextractable radioactivity in liver, kidney, and intestines, indicating that some reactive intermediate(s) may be formed.
The antisickling agent, 5-hydroxymethyl-2-furfural: Other potential pharmacological applications.
Pagare P, McGinn M, Ghatge M, Shekhar V, Alhashimi R, Daniel Pierce B Med Res Rev. 2024; 44(6):2707-2729.
PMID: 38842004 PMC: 11452283. DOI: 10.1002/med.22062.
Alhashimi R, Ahmed T, Alghanem L, Pagare P, Huang B, Ghatge M Pharmaceutics. 2023; 15(11).
PMID: 38004527 PMC: 10675597. DOI: 10.3390/pharmaceutics15112547.
Guan D, Li Y, Cui Y, Zhao H, Dong N, Wang K Acta Biochim Biophys Sin (Shanghai). 2023; 55(8):1222-1233.
PMID: 37431183 PMC: 10448060. DOI: 10.3724/abbs.2023105.
X-ray crystallography and sickle cell disease drug discovery-a tribute to Donald Abraham.
Donkor A, Pagare P, Mughram M, Safo M Front Mol Biosci. 2023; 10:1136970.
PMID: 37293554 PMC: 10244664. DOI: 10.3389/fmolb.2023.1136970.
Bodin L, Del Mazo J, Grasl-Kraupp B, Hogstrand C, Leblanc J, Bignami M EFSA J. 2022; 20(4):e07227.
PMID: 35475165 PMC: 9019825. DOI: 10.2903/j.efsa.2022.7227.